Similarly, a prospective, parallel-assignment, open-label, phase III study examined changes in MMSE scores following 12-week liraglutide treatment in individuals with diabetes (glycated hemoglobin [HbA1c] > 7.0% and on oral antidiabetic drugs or insulin for at least 3 months). Here, INS is linked to diabetes mellitus.